Nubeqa

A drug used alone or with docetaxel to treat adults with certain types of prostate cancer. Nubeqa is used in patients whose cancer has spread to other parts of the body and responds to treatment that lowers testosterone levels or whose cancer has not spread to other parts of the body and no longer responds to treatment that lowers testosterone levels. It is also being studied in the treatment of other types of cancer. Nubeqa binds to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and may cause cancer cells to grow. Nubeqa blocks these proteins and may keep cancer cells from growing. It is a type of antiandrogen. Also called darolutamide.